0.788
0.25%
0.002
After Hours:
.79
0.002
+0.25%
Predictive Oncology Inc stock is traded at $0.788, with a volume of 102.66K.
It is up +0.25% in the last 24 hours and down -17.57% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$0.786
Open:
$0.7651
24h Volume:
102.66K
Relative Volume:
0.04
Market Cap:
$5.28M
Revenue:
$1.78M
Net Income/Loss:
$-13.98M
P/E Ratio:
-0.1628
EPS:
-4.84
Net Cash Flow:
$-13.49M
1W Performance:
-3.42%
1M Performance:
-17.57%
6M Performance:
-69.10%
1Y Performance:
-75.37%
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Predictive Oncology Inc Stock (POAI) Latest News
Predictive Oncology (NASDAQ:POAI) Shares Pass Below Two Hundred Day Moving Average of $1.42 - Defense World
Payoneer Global (NASDAQ:PAYO) Reaches New 52-Week High at $7.67 - MarketBeat
Strong Market Opportunities For OneStream Amid Rising Demand for AI-Driven Financial Solutions, Analyst Says - Yahoo Finance UK
TD Cowen analysts reiterates a Buy rating for PureCycle Technologies Inc (PCT) - Knox Daily
Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS) - SETE News
Paylocity price target raised to $186 from $171 at TD Cowen - TipRanks
Paycor HCM, Inc. (PYCR): Short Seller Sentiment is Bearish on This AI Stock Under $50 - Yahoo Finance UK
Global Artificial Intelligence in Genomics Market Expected to Reach $ 5.5 Billion by 2032, Growing at 43.2% CAGR - 대구포스트
(PTGX) Trading Signals - Stock Traders Daily
Predictive Oncology faces NASDAQ delisting over share price By Investing.com - Investing.com Canada
Predictive Oncology faces NASDAQ delisting over share price - Investing.com
Predictive Oncology faces NASDAQ delisting over share price By Investing.com - Investing.com UK
Payoneer Global (NASDAQ:PAYO) Reaches New 52-Week High at $7.64 - Defense World
Paycor HCM Inc (PYCR) can make a big difference with a little luck - SETE News
(COHN) Technical Pivots with Risk Controls - Stock Traders Daily
Piper Sandler maintains Overweight rating on Opko Health shares on strong prospects - Investing.com Canada
PureCycle Technologies Inc (PCT) rating reiterates by TD Cowen - Knox Daily
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Tech Funding News
Cancer Profiling Market Growth Analysis, Industry Forecast To 2033 - WhaTech
Global Artificial Intelligence in Genomics Market Size, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2024-2032 - 대구포스트
AI in Genomics Global Market Innovations Investigated by Technological Innovations and Market Growth - WhaTech
1 Incredible AI Stock You Probably Won't See on CNBC - 24/7 Wall St.
Payoneer Global (NASDAQ:PAYO) Shares Down 2.1% - Defense World
Predictive Oncology (NASDAQ:POAI) Stock Passes Below 200-Day Moving Average of $1.56 - Defense World
SINTX Techs (NASDAQ:SINT) Stock Quotes, Forecast and News Summary - Benzinga
Can PureCycle Technologies Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below Two Hundred Day Moving Average of $1.65 - Defense World
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Predictive Oncology (NASDAQ:POAI) Shares Cross Below 200-Day Moving Average of $1.73 - Defense World
7 Mighty Medical Stocks That Will Keep Getting Stronger in 2024 - MarketBeat
Predictive Oncology confirms biobank sample stability By Investing.com - Investing.com Canada
Predictive Oncology confirms biobank sample stability - Investing.com
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery - Yahoo Finance
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery - StockTitan
Predictive Oncology confirms biobank sample stability - Investing.com India
Predictive Oncology Inc. (POAI): A Popular AI Penny Stock Under $5 - Yahoo Finance
7 Most Popular AI Penny Stocks Under $5 - Insider Monkey
Equities Analysts Issue Forecasts for Predictive Oncology Inc.’s FY2024 Earnings (NASDAQ:POAI) - Defense World
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update - MSN
Q3 2024 Earnings Estimate for Predictive Oncology Inc. Issued By HC Wainwright (NASDAQ:POAI) - Defense World
Predictive Oncology Inc. (NASDAQ:POAI) Is Expected To Breakeven In The Near Future - Yahoo Finance
Predictive Oncology (NASDAQ:POAI) Now Covered by HC Wainwright - Defense World
POAI (Predictive Oncology) EV-to-Revenue : 0.92 (As of Aug. 19, 2024) - GuruFocus.com
POAI (Predictive Oncology) Price-to-Free-Cash-Flow : N/A (As of Aug. 18, 2024) - GuruFocus.com
POAI (Predictive Oncology) Enterprise Value : $2.16 Mil (As of Aug. 17, 2024) - GuruFocus.com
Predictive Oncology (NASDAQ:POAI) Shares Cross Below 200 Day Moving Average of $1.88 - Defense World
Predictive Oncology (FRA:S1K) Intrinsic Value: DCF (Earnings Based) : €-55.09 (As of Aug. 16, 2024) - GuruFocus.com
Predictive Oncology (FRA:S1K) EV-to-Revenue : 2.02 (As of Aug. 17, 2024) - GuruFocus.com
Predictive Oncology Inc. (NASDAQ:POAI) Q2 2024 Earnings Call Transcript - Insider Monkey
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024 - MSN
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):